Personal information

Verified email domains

Activities

Employment (5)

AstraZeneca (United Kingdom): Cambridge, GB

2022-10-17 to present | Statistical Science Director (Respiratory and Immunology, R&D)
Employment
Source: Self-asserted source
Enti Spata

University of Oxford: Oxford, Oxfordshire, GB

2015-10-19 to 2022-09-01 | Medical Statistician (Nuffield Department of Population Health)
Employment
Source: Self-asserted source
Enti Spata

University of Leicester: Leicester, GB

2014-10-01 to 2015-10-16 | Research Associate (Health Sciences)
Employment
Source: Self-asserted source
Enti Spata

University of Leicester: Leicester, GB

2012-09-30 to 2014-09-30 | NIHR Research Methods Fellowship (Health Sciences)
Employment
Source: Self-asserted source
Enti Spata

Ministry of Education: Athens, GR

2011-02-01 to 2011-06-30 | Trainee Statistician (General Secretariat for Research and Technology)
Employment
Source: Self-asserted source
Enti Spata

Education and qualifications (3)

University of Oxford: Oxford, Oxfordshire, GB

(Nuffield Department of Population Health; St Catherine's College)
Education
Source: check_circle
ORCID Integration at the University of Oxford

University of Leicester: Leicester, GB

2012-09-30 to 2013-09-09 | MSc in Medical Statistics (Health Sciences)
Education
Source: Self-asserted source
Enti Spata

Athens University of Economics and Business: Athens, GR

2007-09-30 to 2011-09-01 | BSc (Statistics)
Education
Source: Self-asserted source
Enti Spata

Works (12)

Evaluation of S/F94 as a proxy for COVID-19 severity

2022-09-27 | Preprint
Contributors: Maaike C Swets; Steven Kerr; James Scott-Brown; Adam B Brown; Rishi Gupta; Jonathan E Millar; Enti Spata; Fiona McCurrach; Andrew D Bretherick; Annemarie Docherty et al.
Source: check_circle
Crossref

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022-03-03 | Preprint
Contributors: Peter W Horby; Jonathan R Emberson; Marion Mafham; Mark Campbell; Leon Peto; Guilherme Pessoa-Amorim; Enti Spata; Natalie Staplin; Catherine Lowe; David R Chadwick et al.
Source: check_circle
Crossref

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021-06-16 | Other
Contributors: Peter W Horby; Marion Mafham; Leon Peto; Mark Campbell; Guilherme Pessoa-Amorim; Enti Spata; Natalie Staplin; Jonathan R Emberson; Benjamin Prudon; Paul Hine et al.
Source: check_circle
Crossref

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021-06-08 | Other
Contributors: Peter W Horby; Guilherme Pessoa-Amorim; Natalie Staplin; Jonathan R Emberson; Mark Campbell; Enti Spata; Leon Peto; Nigel J Brunskill; Simon Tiberi; Victor Chew et al.
Source: check_circle
Crossref

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021-05-18 | Other
Contributors: Peter W Horby; Mark Campbell; Enti Spata; Jonathan R Emberson; Natalie Staplin; Guilherme Pessoa-Amorim; Leon Peto; Martin Wiselka; Laura Wiffen; Simon Tiberi et al.
Source: check_circle
Crossref

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021-03-10 | Other
Contributors: Peter W Horby; Lise Estcourt; Leon Peto; Jonathan R Emberson; Natalie Staplin; Enti Spata; Guilherme Pessoa-Amorim; Mark Campbell; Alistair Roddick; Nigel E Brunskill et al.
Source: check_circle
Crossref

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

2021-02-11 | Other
Contributors: Peter W Horby; Mark Campbell; Natalie Staplin; Enti Spata; Jonathan R Emberson; Guilherme Pessoa-Amorim; Leon Peto; Christopher E Brightling; Rahuldeb Sarkar; Koshy Thomas et al.
Source: check_circle
Crossref

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2020-12-14 | Other
Contributors: Peter W Horby; Alistair Roddick; Enti Spata; Natalie Staplin; Jonathan R Emberson; Guilherme Pessoa-Amorim; Leon Peto; Mark Campbell; Christopher Brightling; Ben Prudon et al.
Source: check_circle
Crossref

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

The Lancet Gastroenterology & Hepatology
2018-04 | Journal article
Part of ISSN: 2468-1253
Source: Self-asserted source
Enti Spata

Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints

Statistical Methods in Medical Research
2017-10 | Journal article
Part of ISSN: 0962-2802
Part of ISSN: 1477-0334
Source: Self-asserted source
Enti Spata

Evaluation of the use of a parent questionnaire to provide later health status data: the PANDA study

Archives of Disease in Childhood - Fetal and Neonatal Edition
2016-07 | Journal article
Part of ISSN: 1359-2998
Part of ISSN: 1468-2052
Source: Self-asserted source
Enti Spata

A Parent Questionnaire for Developmental Screening in Infants Born Late and Moderately Preterm

PEDIATRICS
2014-07-01 | Journal article
Part of ISSN: 0031-4005
Part of ISSN: 1098-4275
Source: Self-asserted source
Enti Spata